OMERS Ventures leads $10 mln Series B funding of InteraXon

Canadian brain health technology company InteraXon Inc has received $10 million in Series B financing. The round was led by OMERS Ventures, its second investment in the company since 2013, and was joined by Felicis Ventures, Horizons Ventures and Flextronics Lab IX. As part of the round, Kent Thexton, managing director of OMERS Ventures, is joining InteraXon's board of directors. Based in Toronto, InterAxon is the maker of Muse, a wearable brain fitness tool for reducing stress, increasing focus, and improving sleep and mental performance. Founded in 2007, the company has raised close to $22 million in venture capital investment, including the latest round.

CanadaNorth AmericaBriefs